Trump wanted to advance the ‘most favored nation’ policy in his first term but faced resistance from industry and the courts.

U.S. President Donald Trump is expected to sign an executive order as early as next week that would revive an effort to decrease drug costs by tying the amount the government pays for some medicines to lower prices abroad,

A game changer. One of the most notable aspects of this order is the proposal to reduce the price of insulin to just $0.03 for low-income and uninsured patients.